Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status.
Publication
, Journal Article
Blumenthal, RS; Aslam, MI; McEvoy, JW
Published in: JACC. Cardiovascular imaging
February 2018
Published In
JACC. Cardiovascular imaging
DOI
EISSN
1876-7591
ISSN
1936-878X
Publication Date
February 2018
Volume
11
Issue
2 Pt 1
Start / End Page
231 / 233
Related Subject Headings
- Primary Prevention
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Eligibility Determination
- Coronary Artery Disease
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Blumenthal, R. S., Aslam, M. I., & McEvoy, J. W. (2018). Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status. JACC. Cardiovascular Imaging, 11(2 Pt 1), 231–233. https://doi.org/10.1016/j.jcmg.2017.02.019
Blumenthal, Roger S., M Imran Aslam, and J William McEvoy. “Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status.” JACC. Cardiovascular Imaging 11, no. 2 Pt 1 (February 2018): 231–33. https://doi.org/10.1016/j.jcmg.2017.02.019.
Blumenthal RS, Aslam MI, McEvoy JW. Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status. JACC Cardiovascular imaging. 2018 Feb;11(2 Pt 1):231–3.
Blumenthal, Roger S., et al. “Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status.” JACC. Cardiovascular Imaging, vol. 11, no. 2 Pt 1, Feb. 2018, pp. 231–33. Epmc, doi:10.1016/j.jcmg.2017.02.019.
Blumenthal RS, Aslam MI, McEvoy JW. Using Trial Eligibility to Personalize Statin Therapy Appears No More Accurate Than a Coin Flip in Determining High-Risk Status. JACC Cardiovascular imaging. 2018 Feb;11(2 Pt 1):231–233.
Published In
JACC. Cardiovascular imaging
DOI
EISSN
1876-7591
ISSN
1936-878X
Publication Date
February 2018
Volume
11
Issue
2 Pt 1
Start / End Page
231 / 233
Related Subject Headings
- Primary Prevention
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Humans
- Eligibility Determination
- Coronary Artery Disease
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology